期刊文献+

分子信标实时PCR检测瘢痕相关p53基因SNP方法的建立 被引量:4

Establishment of molecular beacon real-time PCR for detecting p53 gene single nucleotide polymorphism
下载PDF
导出
摘要 目的建立分子信标实时PCR检测病理性瘢痕相关p53基因第72密码子单核苷酸多态性的新方法。方法采集瘢痕疙瘩患者外周血28例,提取DNA并用分子信标PCR检测p53基因多态性。设计一对p53基因第72密码子单核苷酸多态性荧光分子信标探针,荧光定量PCR检测该位点单核苷酸(SNP),并与反向斑点杂交法,DNA直接测序等方法比较。结果定量荧光PCR荧光分子信标检测的结果与测序结果吻合率达到100%,高于反向斑点杂交法且简便快捷。结论分子信标实时PCR检测技术适合临床p53基因第72密码子单核苷酸多态性快速诊断。 Objective To establish a method based on molecular beacon real-time PCR for detecting single nucleotide polymorphisms(SNP) in codon 72 of scar-related p53 gene.Methods Two fluorescence-labeled molecular beacon probes were synthesized targeting CCC/CGC SNP of p53 codon 72.The genomic DNA was extracted from the peripheral blood of 28 patients with keloid,and the CCC/CGC SNP of P53 gene codon 72 were assayed with molecular beacon real-time PCR.The results of SNP typing were compared with the results of reverse dot hybridization and confirmed by direct DNA sequencing.Results The goodness of fit of this method was 100% in comparison with direct DNA sequencing,higher than that of reverse dot hybridization.Conclusion Molecular beacon real-time PCR is suitable for rapid clinical detection of SNPs in p53 gene.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第11期1875-1878,共4页 Journal of Southern Medical University
基金 国家自然科学基金(30901566 81071589) 广东省自然科学基金(9151051501000025)~~
关键词 P53基因 单核苷酸多态性 分子信标定量PCR 瘢痕 p53 gene single nucleotide polymorphism molecular beacon real-time PCR scar
  • 相关文献

参考文献5

二级参考文献44

  • 1杜长征,李惠平,马力文,付卫,王墨培,贾廷珍,赵红梅,侯宽永.中国乳腺癌患者p53表达临床生物学意义的Meta分析[J].中国癌症杂志,2005,15(6):514-517. 被引量:23
  • 2Lvkovic-Kapicl T,Knezevic-Usaj S,Panjkovic M,et al.The influence of aging on pathologic and immunobiologic parameters of invasive ductal breast carcinoma.[J].Vojnosanit Pregl,2006,63(11):921-927.
  • 3Soussi T,Beroud C.Assessing TP53 status in human tumors to evaluate clinical outcome[J].Nat Rev Cancer,2001,1(3):233-240.
  • 4Petitjean A,Mathe E,Kato S,et al.Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:Lessons from recent developments in the IARC TP53 database[J].Hum Mutant,2007,28(6):622-629.
  • 5Do TN,Rosal RV,Drew L,et al.Preferential induction of necrosis in human breast cancer cell by a p53 peptide derived from the MDM2 binding site[J].Oncogcne,2003,22(10):1431-1444.
  • 6Wojcik I,Szybka M,Golanska E,et al.Abnormalities of the P53,MDM2,BCL2 and BAX genes in acute leukemla's[J].Neoplasm,2005,52(4):318-324.
  • 7Vousden KH,Lane DP.p53 in health and disease[J].Nat Rev Mol Cell Bicol,2007,8:275-283.
  • 8Bartek J,Iggo R,Gaannon J,et al.Genetic and immunochemical analysis of mutant p53 in human breast cancer cell line[J].Oncogene,1990,5(6):893-899.
  • 9Norberg T,Klaar S,Karf G,et al.Increased p53 mutation frequency during tumor progression-results from a breast cancer cohort[J].Cancer Res,2001,61(22):8317-8321.
  • 10Bensaad K,Tsuruta A,Selak MA,et al.A p53-inducible regulator of glycolsis and apoptosis[J].Cell,2006,126(1):107-120.

共引文献14

同被引文献56

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部